Life Sciences
ConcertAI is expanding its collaboration with Janssen to improve study design and increase diversity in clinical trials.
The pharmacists argue the partnership will hurt independent pharmacies and hides the real issues behind high drug costs.
Big Health CEO Peter Hames discusses how apps like his are changing therapy.
Also, Ujala Cygnus opens an ICU telemedicine facility in New Delhi.
The platform has served as the basis of clinical research studies at multiple institutions, including UCSF and Stanford University.
The acquisition will enable Verily to build out its clinical trial platform, Baseline, which houses technology for decentralized and hybrid trials.
MobiHealthNews talks with AstraZeneca’s chief commercial digital officer about partnerships, COVID-19 and what's next for digital health.
HIMSS21
Industry leaders discussed the state of healthcare data analytics today at HIMSS21.
The study will look at how intensive non-surgical periodontal therapy and home dental hygiene impact overall health.
The researchers created a statistical method that extracts a person's circadian rhythm based on heart rate data provided by their smartwatch.